Literature DB >> 1377008

Karyotype and T-cell receptor expression in T-lineage acute lymphoblastic leukemia.

L M Secker-Walker1, D Campana, J M Hawkins, R E Sampson, E Coustan-Smith.   

Abstract

The relationship between karyotype and expression of the T-cell receptor (TCR) proteins was examined in 19 patients with T-lineage acute lymphoblastic leukemia (T-ALL). All patients expressed CD3 molecules in the cytoplasm or on the cell membrane. Patients were classified according to TCR expression thus: no TCR expression (TCR-), six cases; cytoplasmic expression of TCR beta chain (cTCRB) only, six cases; membrane expression of TCR alpha and beta chains (mTCRAB), five cases; membrane expression of TCR gamma and delta (mTCRGD), two cases. A chromosomally abnormal clone was detected in 15 cases. The most common site of chromosomal change was at 14q11 (seven cases), the chromosomal band to which TCRA and TCRD have been mapped; as a deletion (two cases); or as a translocation with reciprocal breakpoints in bands containing the TCRG (7p15); TCRB (7q35); or putative oncogenes HOXII (10q24), RBTN2 (11p13) or MYC (8q24) genes. Breakpoints were also seen in 6q (three cases), 9p (two cases), or 11q23 (two cases). The following observations were made: All four chromosomally normal cases lacked TCR expression (TCR-). Breakpoints at 14q11 were found in one of six TCR- cases, four of six cTCRB cases, and two of five mTCRAB cases. Abnormalities of 6q and of 9p were seen only in cases with full TCR expression (mTCRAB or mTCRGD).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377008     DOI: 10.1002/gcc.2870040106

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  1 in total

1.  Chromosome abnormalities in T-cell acute lymphoblastic leukemia in Korea.

Authors:  Joonhong Park; Myungshin Kim; Hae Kyung Lee; Yonggoo Kim; Kyungja Han; Jungok Son; Seok Lee; Nack-Gyun Chung; Bin Cho
Journal:  Int J Hematol       Date:  2014-01-29       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.